Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 7

1.

A phase II study of allogeneic natural killer cell therapy to treat patients with recurrent ovarian and breast cancer.

Geller MA, Cooley S, Judson PL, Ghebre R, Carson LF, Argenta PA, Jonson AL, Panoskaltsis-Mortari A, Curtsinger J, McKenna D, Dusenbery K, Bliss R, Downs LS, Miller JS.

Cytotherapy. 2011 Jan;13(1):98-107. doi: 10.3109/14653249.2010.515582.

PMID:
20849361
2.

Therapeutic applications: natural killer cells in the clinic.

Miller JS.

Hematology Am Soc Hematol Educ Program. 2013;2013:247-53. doi: 10.1182/asheducation-2013.1.247. Review.

PMID:
24319187
3.

Clinical utility of natural killer cells in cancer therapy and transplantation.

Knorr DA, Bachanova V, Verneris MR, Miller JS.

Semin Immunol. 2014 Apr;26(2):161-72. doi: 10.1016/j.smim.2014.02.002. Review.

PMID:
24618042
5.

Treatment-related mortality and graft-versus-leukemia activity after allogeneic stem cell transplantation for chronic lymphocytic leukemia using intensity-reduced conditioning.

Dreger P, Brand R, Hansz J, Milligan D, Corradini P, Finke J, Deliliers GL, Martino R, Russell N, Van Biezen A, Michallet M, Niederwieser D; Chronic Leukemia Working Party of the EBMT..

Leukemia. 2003 May;17(5):841-8. Review.

PMID:
12750695
6.

Natural killer cells in the treatment of high-risk acute leukaemia.

Locatelli F, Moretta F, Brescia L, Merli P.

Semin Immunol. 2014 Apr;26(2):173-9. doi: 10.1016/j.smim.2014.02.004. Review.

PMID:
24613727
7.

Impact of dietary components on NK and Treg cell function for cancer prevention.

Kim YS, Sayers TJ, Colburn NH, Milner JA, Young HA.

Mol Carcinog. 2015 Sep;54(9):669-78. doi: 10.1002/mc.22301. Review.

PMID:
25845339
Items per page

Supplemental Content

Support Center